Literature DB >> 381203

Immunotherapy of guinea pig line 10 hepatoma with nonliving BCG cells in aqueous medium.

A Bekierkunst, M B Goren.   

Abstract

Killed BCG cells suspended in 1.5% carboxymethylcellulose cured guinea pigs with established line 10 tumors in a high percentage of cases. The bacterial preparation of BCG in carboxymethylcellulose displayed a stronger tumor regressive activity and the process of healing was accelerated when endotoxin from a rough (Re) strain of Salmonella typhimurium was added to the BCG bacilli.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 381203      PMCID： PMC414380          DOI： 10.1128/iai.24.3.817-820.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  21 in total

1.  Activation of guinea pig macrophages by bacterial lipopolysaccharide requires bone marrow-derived lymphocytes.

Authors:  J M Wilton; D L Rosenstreich; J J Oppenheim
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

2.  Glucan: attempts to demonstrate therapeutic activity against five syngeneic tumors in guinea pigs and mice.

Authors:  J T Hunter; M S Meltzer; E Ribi; I J Fidler; M G Hanna; B Zbar; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1978-02       Impact factor: 13.506

3.  Immunopotentiation with BCG. I. Immune response to different strains and preparations.

Authors:  G B Mackaness; D J Auclair; P H Lagrange
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

4.  Antigenicity of a new diethylnitrosamine-induced transplantable guinea pig hepatoma: pathology and formation of ascites variant.

Authors:  H J Rapp; W H Churchill; B S Kronman; R T Rolley; W G Hammond; T Borsos
Journal:  J Natl Cancer Inst       Date:  1968-07       Impact factor: 13.506

5.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

6.  Treatment of mycosis fungoides with heat-killed BCG and cord factor.

Authors:  H A Cohen; A Bekierkunst
Journal:  Dermatologica       Date:  1979

7.  Topical treatment of Kaposi's sarcoma, basal cell carcinoma and solar keratosis with ointment of BCG and cord factor.

Authors:  H A Cohen; A Bekierkunst
Journal:  Dermatologica       Date:  1979

Review 8.  Immunotherapy with nonviable microbial components.

Authors:  E Ribi; K C Milner; D L Granger; M T Kelly; K Yamamoto; W Brehmer; R Parker; R F Smith; S M Strain
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

9.  Immunotherapy of cancer with nonliving mycobacteria and cord factor (trehalose-6,6'-dimycolate) in aqueous medium.

Authors:  A Bekierkunst
Journal:  J Natl Cancer Inst       Date:  1976-10       Impact factor: 13.506

10.  Activated macrophages release a factor which lyses malignant cells but not normal cells.

Authors:  G A Currie; C Basham
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.